Antibe Therapeutics is a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine. On June 1, 2020, the company announced positive results in the final Phase 2 trial of its first drug. More information...
According to PR-model, antibethera.com is ranked 1,840,687th in multilingual Wikipedia, in particular this website is ranked 1,019,955th in English Wikipedia.
The website is placed before legionline.com and after valtrebbiastoriaearte.it in the BestRef global ranking of the most important sources of Wikipedia.
